RETRACTION article
Front. Genet.
Sec. Cancer Genetics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1655052
Retraction: EZH2-Mediated microRNA-375 Upregulation Promotes Progression of Breast Cancer via the Inhibition of FOXO1 and the p53 Signaling Pathway Please find the retraction statement below
Provisionally accepted
- Frontiers Media SA, Lausanne, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Retraction: EZH2-Mediated microRNA-375 Upregulation Promotes Progression of Breast Cancer via the Inhibition of FOXO1 and the p53 Signaling PathwayPlease find the retraction statement below: Xin Guan , Aiping Shi , Yabin Zou , Meiyang Sun , Yue Zhan , Yi Dong , Zhimin Fan (2021) Ezh2-mediated microrna-375 upregulation promotes progression of breast cancer via the inhibition of FOXO1 and the p53 signaling pathway, Frontiers in Genetics, 12. doi:10.3389/fgene.2021.633756., https://doi.org/10.3389/fgene.2021.633756“Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. This retraction was approved by the Chief Editors of Genetics and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.”
Keywords: breast cancer, miR-375, EZH2, FoxO1, p53
Received: 27 Jun 2025; Accepted: 27 Jun 2025.
Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.